SRMS and breast cancer: The possibility that SRMS is overexpressed or dysregulated in various malignancies was explored previously, showing that SRMS was overexpressed in six of eight breast cancer cell lines tested, exhibiting the highest levels of expression in HBL-100 and the lowest expression in MDA-MB-468 and AU565 cells [9].